165 related articles for article (PubMed ID: 34109395)
1. Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged ≥65 years.
Cooper H; Wells S; Mehta S
Int J Epidemiol; 2022 May; 51(2):604-614. PubMed ID: 34109395
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
[TBL] [Abstract][Full Text] [Related]
3. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
[TBL] [Abstract][Full Text] [Related]
4. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
[TBL] [Abstract][Full Text] [Related]
5. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
[TBL] [Abstract][Full Text] [Related]
6. A cardiovascular risk prediction model for older people: Development and validation in a primary care population.
van Bussel EF; Richard E; Busschers WB; Steyerberg EW; van Gool WA; Moll van Charante EP; Hoevenaar-Blom MP
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1145-1152. PubMed ID: 31294917
[TBL] [Abstract][Full Text] [Related]
7. The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice.
Hageman SHJ; Dorresteijn JAN; Pennells L; van Smeden M; Bots ML; Di Angelantonio E; Visseren FLJ
Eur J Prev Cardiol; 2023 Nov; 30(16):1741-1747. PubMed ID: 37338108
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular disease.
Holt A; Batinica B; Liang J; Kerr A; Crengle S; Hudson B; Wells S; Harwood M; Selak V; Mehta S; Grey C; Lamberts M; Jackson R; Poppe KK
Eur J Prev Cardiol; 2024 Jan; 31(2):218-227. PubMed ID: 37767960
[TBL] [Abstract][Full Text] [Related]
9. Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approach.
Barbieri S; Mehta S; Wu B; Bharat C; Poppe K; Jorm L; Jackson R
Int J Epidemiol; 2022 Jun; 51(3):931-944. PubMed ID: 34910160
[TBL] [Abstract][Full Text] [Related]
10. Performance of cardiovascular disease risk prediction equations in more than 14 000 survivors of cancer in New Zealand primary care: a validation study.
Tawfiq E; Selak V; Elwood JM; Pylypchuk R; Tin ST; Harwood M; Grey C; McKeage M; Wells S
Lancet; 2023 Feb; 401(10374):357-365. PubMed ID: 36702148
[TBL] [Abstract][Full Text] [Related]
11. Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
Livingstone SJ; Guthrie B; Donnan PT; Thompson A; Morales DR
BMC Med; 2022 May; 20(1):152. PubMed ID: 35505353
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
[TBL] [Abstract][Full Text] [Related]
13. External validation of the QLifetime cardiovascular risk prediction tool: population cohort study.
Livingstone S; Morales DR; Fleuriot J; Donnan PT; Guthrie B
BMC Cardiovasc Disord; 2023 Apr; 23(1):194. PubMed ID: 37061672
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of the American Heart Association's PREVENT Equations.
Khan SS; Matsushita K; Sang Y; Ballew SH; Grams ME; Surapaneni A; Blaha MJ; Carson AP; Chang AR; Ciemins E; Go AS; Gutierrez OM; Hwang SJ; Jassal SK; Kovesdy CP; Lloyd-Jones DM; Shlipak MG; Palaniappan LP; Sperling L; Virani SS; Tuttle K; Neeland IJ; Chow SL; Rangaswami J; Pencina MJ; Ndumele CE; Coresh J;
Circulation; 2024 Feb; 149(6):430-449. PubMed ID: 37947085
[TBL] [Abstract][Full Text] [Related]
15. Performance of CVD risk equations for older patients assessed in general practice: a cohort study.
Wells S; Pylypchuk R; Mehta S; Kerr A; Selak V; Poppe K; Grey C; Jackson R
N Z Med J; 2020 Jun; 133(1517):32-55. PubMed ID: 32595220
[TBL] [Abstract][Full Text] [Related]
16. Assessing risk factors of non-fatal outcomes amid a competing risk of mortality: the example of hip fracture.
Buzkova P; Barzilay JI; Mukamal KJ
Osteoporos Int; 2019 Oct; 30(10):2073-2078. PubMed ID: 31256203
[TBL] [Abstract][Full Text] [Related]
17. Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
Selak V; Jackson R; Poppe K; Wu B; Harwood M; Grey C; Pylypchuk R; Mehta S; Kerr A; Wells S
Ann Intern Med; 2019 Mar; 170(6):357-368. PubMed ID: 30802900
[TBL] [Abstract][Full Text] [Related]
18. Predicting cardiovascular disease risk across the atherosclerotic disease continuum.
Poppe KK; Wells S; Jackson R; Doughty RN; Kerr AJ
Eur J Prev Cardiol; 2022 Feb; 28(18):2010-2017. PubMed ID: 33624049
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients.
Chen X; Tu Q; Wang D; Liu J; Qin Y; Zhang Y; Xiang Q
Public Health; 2023 Jul; 220():127-134. PubMed ID: 37315498
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction models.
Mehta S; Jackson R; Wells S; Harrison J; Exeter DJ; Kerr AJ
Clin Epidemiol; 2018; 10():133-141. PubMed ID: 29391835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
